Home > Investing > Companies

Mediq

Price
 
Price € 9,62
Change € 0,05
Change % 0,53%
Open € 9,62
High € 9,62
Low € 9,62
Volume 646
Profile
 
Profile: Mediq is an international retail and distribution company for pharmaceuticals and medical supplies. Mediq is leader in the Netherlands. Mediq is primarily a holding company of several subsidiaries. One example is a chain of pharmacies in-house in the Netherlands and Poland. Mediq is also active as a wholesaler to pharmacies, doctors, hospitals and home care. The company is also still active in some other European countries. Mediq was established in 1899 as a cooperative Pharmacists Association and is listed since 1992 on Euronext Amsterdam.
Site: http://www.mediq.com
Industry: Pharmaceutical
Description: Companies in the pharmaceutical industry develop and sell drugs. In addition, licenses on newly developed drugs are sold to other companies. Medications are strictly supervised by different supervisors. This, and the complex process of developing new drugs results in the long development time before a product makes it to the market. Companies that develop new drugs benefit from long-term protection of their products through patents. This allows them to make money on a new drug.
2011
 

Profit and loss

Net profit (x 1 mln) € 73,40 Turnover (x 1 mln) € 2.755,90
Cashflow (x 1 mln) Tooltip € 111,30 Net cashflow (x 1 mln) Tooltip € 132,00

Balance

Private equity (x 1 mln) € 539,60 Foreign equity (x 1 mln) € 819,50
Current assets (x 1 mln) € 723,70 Current liabilities (x 1 mln) € 429,90
Working capital (x 1 mln) € 293,80 Balance total (x 1 mln) € 1.376,20

Share

Outstanding shares (x 1 mln) 58,500 Price year-end € 11,77
Dividend per share € 0,46 Earnings per share € 1,25
Dividend yield 3,91% Cashflow per share € 1,90
Intrinsic value € 9,22 Net cashflow per share € 2,26
Price/intrinsic value 1,276

Key figures

Price/earnings 9,381 Price/cashflow 6,186
Price/net cashflow 5,216 Stockmarket value (x 1 mln) € 688,55
Solvability Tooltip 0,392 Solvability Tooltip 1,679
Return on private equity 13,60% Return on total equity 5,33%
Current ratio 1,683 Market value/PE 1,276
Market value/turnover 0,250 Enterprise value/turnover 0,143
History
 
Year 2011 2010 2009 2008 2007
Net profit (x 1 mln) € 73,40 € 76,70 € 74,50 € -127,90 € 95,30
Turnover (x 1 mln) € 2.755,90 € 2.633,90 € 2.602,70 € 2.730,20 € 2.476,60
Price year-end € 11,77 € 14,00 € 12,89 € 9,29 € 19,00
Year high € 14,85 € 16,41 € 13,40 € 20,52 € 28,61
Year low € 10,80 € 12,08 € 5,95 € 8,25 € 18,01
Outstanding shares (x 1 mln) 58,500 59,646 58,283 58,400 59,937
Price/earnings 9,381 10,887 10,084 -4,242 11,950
Earnings per share € 1,25 € 1,29 € 1,28 € -2,19 € 1,59
Dividends € 0,46 - € 0,44 € 0,30 € 0,54
Dividend yield 3,91% - 3,41% 3,23% 2,84%
Pay out 36,66% - 34,42% -13,70% 33,96%
Private equity (x 1 mln) € 539,60 € 510,20 € 454,10 € 364,90 € 561,30
PE per share € 9,22 € 8,55 € 7,79 € 6,25 € 9,36
Balance total (x 1 mln) € 1.376,20 € 1.195,80 € 1.139,40 € 1.117,10 € 1.172,20
Stockmarket value (x 1 mln) € 688,55 € 835,04 € 751,27 € 542,54 € 1.138,80
Number of employees 8.300 8.200 7.800 7.700 7.267